Dubai PR Network, Online Press Release from Dubai and Middle East
Filter PR by
Application for clinical trial of AIM Vaccine's human diploid rabies vaccine

An iterative process is highly effective in increasing the value of large items

HONG KONG SAR - Media OutReach Newswire - 8 November 2024 - AIM Vaccine (06660.HK), the world's second largest supplier of rabies vaccines, announced on 7th November that the application for clinical trial of the iterative-process highly-effective human diploid rabies vaccine developed by the Company has been submitted to the Center for Drug Evaluation (CDE) of National Medical Products Administration of China recently.

According to the announcement, the i iterative-process highly-effective human diploid rabies vaccine developed by AIM Vaccine shows an iterative upgrade compared to the traditional human diploid rabies vaccines of the first generation in many aspects.

The iterative-process highly-effective human diploid rabies vaccine developed by the Company has taken the lead in breaking through the technical bottlenecks of low virus titer and low yield in the traditional process. It has been optimized and innovated in the purification process with the product quality and safety significantly improved.

Compared with the number of traditional rabies vaccinations, this product developed by the Group can be vaccinated with either 'five-needle approach', 'simple four-needle approach' or '2-1-1 four-needle approach', which is more flexible and convenient.

There are two kinds of rabies vaccines, namely the serum-containing rabies vaccine and the serum-free rabies vaccine. However, no serum-free rabies vaccine has been registered or marketed yet. The mainstream Vero cell rabies vaccine and human diploid rabies vaccine currently available in the market are serum-containing rabies vaccines.

Compared with the traditional Vero cell rabies vaccines, human diploid rabies vaccine uses human diploid cells instead of Vero cells, which are homologous to humans and have a natural safety advantage. The human diploid rabies vaccine currently available in the market is 3 to 5 times more expensive than the Vero cell rabies vaccine, with higher product added value.

According to the announcement, AIM Vaccine has completed the construction of an iterative-process high-efficiency human diploid rabies vaccine workshop that meets international standards, and has completed the production of commercial-scale Phase III clinical trial samples, which is capable of producing this product in large scale.

China is the world's largest rabies vaccine market. According to the 2024 interim performance report of AIM Vaccine, the approved lot release volume of China's rabies vaccines increased from 58.80 million in 2019 to 78.50 million in 2021, representing an increase of 33.6%. It is expected that the market scale will increase to RMB22.0 billion by 2030, partially due to the iteration of rabies vaccine products upgrade. With the expansion of the pet market and the popularization of pre-exposure immunity knowledge, it is expected that the demand for human rabies vaccines will continue to grow in the future.
Hashtag: #AIM

The issuer is solely responsible for the content of this announcement.

AIM Vaccine

Posted by : Media Outreach, Jenny
Viewed 0 times
PR Category : Others
Posted on : Friday, November 8, 2024  11:00:00 AM UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of DubaiPRNetwork.com.
Email this article Print this article

Share this article with your friends and followers
NewsVine
Back to Media OutReach

Related Stories

 
 
Most Viewed Press Release posted in the last 7 days
Own Your Valentine's Look With Catrice: Flawless Brows & A Blush That Speaks Love [56933-Views]
SHEGLAM X Hello Kitty Returns for Valentine's Day with an Even Sweeter and Dreamier 2.0 Co... [55715-Views]
Host with Heart: REDTAG's Ramadan Home Collection Elevates Every Gathering [37134-Views]
Under the Patronage of Prince Khalid Al-Faisal, Governor of Makkah Region Experts from the... [35830-Views]
Rybakina edges out jabeur in three-set classic at mubadala abu dhabi open [17556-Views]
Hafeet Rail Awards Three Strategic Contracts and Secures a Landmark Agreement to Advance O... [16076-Views]
Hotpack launches CEO Excellence Awards to recognise outstanding employee performance [15190-Views]
ADNOC distribution reports record EBITDA for FY2024 and accelerates operational growth [13255-Views]
Panasonic and Beamcast join forces to accelerate broadcast innovation in Qatar [12136-Views]
Zayed Sustainability Prize Opens Global Call for Transformative Solutions [9414-Views]
Emirates and Air Peace sign interline agreement, expanding travel choices to 13 cities in ... [9381-Views]
João Almeida battles towards podium as Volta Valenciana heats up [9155-Views]
Manchester City Abu Dhabi Cup returns as more than 2,500 young players from around the wor... [9028-Views]
Ajmal Perfumes Introduces The Untold Stories: A Landmark Collection of Five Exquisite Frag... [8659-Views]
Abu Dhabi Fund for Development strengthens global partnerships and sustainability at World... [8540-Views]
IHG Hotels at Dubai Festival City Unveils Exclusive Culinary Delights, Staycation Packages... [6863-Views]
AD Ports Group Reports Another Year of Record Results in 2024 with 69% YoY Growth in EBITD... [6724-Views]
Etihad Rail Announces Winners of Global Rail Innovation Award [6560-Views]
Gargash Mercedes-Benz Service Center in Deira Embarks on a New Era of Excellence, Innovati... [6392-Views]
Under the patronage of Khaled bin Mohamed bin Zayed, Department of Government Enablement l... [6347-Views]
UAE and Portugal explore ways to enhance cooperation in civil aviation, tourism, clean ene... [6261-Views]
Pogačar and UAE Team Emirates-XRG Set Sights on Victory at Home Race [6064-Views]
João Almeida finishes runner-up at Volta Valenciana [5920-Views]
Human Fraternity Ambassadors Gather to Discuss Peaceful Coexistence at the Zayed Award for... [5699-Views]
Bader Al Ghaith: The Emirati Entrepreneur Driving NO-VA's Success [5449-Views]
 
RSS Facebook Twitter LinkedDin DubaiPRNetwork.com on Instagram
 
Top Sections
 
Top Stories